http://orcid.org/0000-0003-4407-5998
References
- Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. In: Shah PS, editor. Cochrane database of systematic reviews. Chichester, UK: John Wiley & Sons, Ltd; 2010.
- Bellini C, Ergaz Z, Radicioni M, et al. Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multicenter retrospective study. Lymphology 2012;45:91–102.
- Rocha G. Pleural effusions in the neonate. Curr Opin Pulm Med. 2007;13:305–311.
- Rennie J, Roberton NRC. Textbook of neonatology. 3rd ed. Edinburgh: Churchill Livingstone; 1999.
- Ergaz Z, Bar-Oz B, Yatsiv I, et al. Congenital chylothorax: clinical course and prognostic significance. Pediatr Pulmonol. 2009;44:806–811.
- Bialkowski a, Poets CF, Franz a. R. Congenital chylothorax: a prospective nationwide epidemiological study in Germany. Arch Dis Child Fetal Neonatal Ed. 2014;100:F169–F172.
- Resch B, Freidl T, Reiterer F. Povidone–iodine pleurodesis for congenital chylothorax of the newborn. Arch Dis Child – Fetal Neonatal Ed. 2016;101:87–88.
- Büttiker V, Fanconi S, Burger R. Chylothorax in children: guidelines for diagnosis and management. Chest. 1999;116:682–687.
- Barbosa M, Rocha G, Flôr-de-Lima F, et al. Neonatal pleural effusions in a Level III Neonatal Intensive Care Unit. J Pediatr Neonatal Individ Med. 2015;4:e040123. doi: 10.7363/040123
- Bellini C, Hennekam RCM, Fulcheri E, et al. Etiology of nonimmune hydrops fetalis: a systematic review. Am J Med Genet. 2009;149:844–851.